Moreover, immunohistochemistry assay confirmed that IGF2-AS over-expression in HepG2 cells increased CDKN1A expression (Figure 6c), while decreased Ki-67 expression in tumor tissues of xenograft models (Figure 6d). Here, IGF2 is linked to neoplasm.